Mark S. Chambers

8.2k total citations · 1 hit paper
189 papers, 5.7k citations indexed

About

Mark S. Chambers is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Oncology. According to data from OpenAlex, Mark S. Chambers has authored 189 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Pulmonary and Respiratory Medicine, 71 papers in Otorhinolaryngology and 47 papers in Oncology. Recurrent topics in Mark S. Chambers's work include Head and Neck Cancer Studies (65 papers), Oral health in cancer treatment (65 papers) and Cancer Diagnosis and Treatment (28 papers). Mark S. Chambers is often cited by papers focused on Head and Neck Cancer Studies (65 papers), Oral health in cancer treatment (65 papers) and Cancer Diagnosis and Treatment (28 papers). Mark S. Chambers collaborates with scholars based in United States, United Kingdom and Greece. Mark S. Chambers's co-authors include Adam S. Garden, Linda S. Elting, Catherine D. Cooksley, David I. Rosenthal, James C. Lemon, Jack W. Martin, Merrill S. Kies, Ellen F. Manzullo, Edward Rubenstein and Scott B. Cantor and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark S. Chambers

186 papers receiving 5.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The burdens of cancer therapy

2003 500 citations Mark S. Chambers et al. Cancer profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mark S. Chambers	2.4k	2.2k	1.4k	1.1k	692	189	5.7k
Bernard F. A. M. van der Laan	1.6k 0.7×	2.4k 1.1×	1.3k 0.9×	1.8k 1.7×	677 1.0×	187	5.6k
Robert J. Baatenburg de Jong	1.6k 0.7×	3.0k 1.4×	2.1k 1.5×	2.5k 2.4×	607 0.9×	258	8.1k
Colin Hopper	2.6k 1.1×	914 0.4×	657 0.5×	1.2k 1.1×	395 0.6×	243	6.2k
Jens Ahm Sørensen	534 0.2×	858 0.4×	1.4k 1.0×	2.7k 2.5×	360 0.5×	289	6.0k
Luciano Giacomelli	986 0.4×	753 0.3×	1.4k 0.9×	2.2k 2.1×	574 0.8×	247	6.7k
Mark Jorissen	2.1k 0.9×	1.4k 0.7×	265 0.2×	1.6k 1.5×	51 0.1×	177	5.3k
Herbert Riechelmann	562 0.2×	1.3k 0.6×	767 0.5×	932 0.9×	250 0.4×	169	4.4k
Takashi Fujii	1.0k 0.4×	175 0.1×	441 0.3×	1.3k 1.3×	470 0.7×	284	4.3k
Yutaka Yamazaki	475 0.2×	507 0.2×	515 0.4×	349 0.3×	152 0.2×	169	2.3k
John D. Mitchell	1.9k 0.8×	59 0.0×	506 0.4×	1.3k 1.2×	296 0.4×	148	7.1k

Countries citing papers authored by Mark S. Chambers

Since Specialization

Citations

This map shows the geographic impact of Mark S. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Chambers more than expected).

Fields of papers citing papers by Mark S. Chambers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Chambers. The network helps show where Mark S. Chambers may publish in the future.

Co-authorship network of co-authors of Mark S. Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Chambers. A scholar is included among the top collaborators of Mark S. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Chambers. Mark S. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cohen, Lorenzo, Suzanne C. Danhauer, Emily V. Dressler, et al.. (2024). Acupuncture for Chronic Radiation-Induced Xerostomia in Head and Neck Cancer. JAMA Network Open. 7(5). e2410421–e2410421. 8 indexed citations

Na’ara, Shorook, Dan Yaniv, Luana Guimarães de Sousa, et al.. (2024). Intralesional nivolumab in oral potentially malignant disorders: A phase 1 pilot study on safety, tolerability, and preliminary efficacy.. Journal of Clinical Oncology. 42(16_suppl). 6016–6016. 1 indexed citations

Contrera, Kevin J., Renata Ferrarotto, G. Brandon Gunn, et al.. (2024). Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma. Clinical Cancer Research. 31(2). 258–265. 1 indexed citations

Nogueras‐González, Graciela M., et al.. (2023). Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials. SHILAP Revista de lepidopterología. 7(1). 24–40. 9 indexed citations

Aggarwal, Puja, Katherine A. Hutcheson, Ryan P. Goepfert, et al.. (2022). Risk factors associated with patient‐reported fatigue among long‐term oropharyngeal carcinoma survivors. Head & Neck. 44(4). 952–963. 4 indexed citations

Diao, Kevin, Dorothy Lombe, Rebecca S. Tidwell, et al.. (2021). Implementation of an International Virtual Clinical Research Course for Clinical Oncology Fellows at a Cancer Teaching Hospital in Zambia. International Journal of Radiation Oncology*Biology*Physics. 111(3). e346–e347. 1 indexed citations

Aggarwal, Puja, Katherine A. Hutcheson, Adam S. Garden, et al.. (2021). Determinants of patient‐reported xerostomia among long‐term oropharyngeal cancer survivors. Cancer. 127(23). 4470–4480. 18 indexed citations

Nogueras‐González, Graciela M., et al.. (2021). Medication-Related Osteonecrosis of the Jaw in Patients Treated Concurrently with Antiresorptive and Antiangiogenic Agents: Systematic Review and Meta-Analysis. SHILAP Revista de lepidopterología. 4(4). 196–207. 11 indexed citations

Hofstede, Theresa M., et al.. (2021). Combined rehabilitation of a lower lip defect after resection of floor of mouth cancer: A clinical report. Journal of Prosthetic Dentistry. 128(6). 1369–1374. 2 indexed citations

10.

Cardoso, Richard C., Mona Kamal, Jhankruti Zaveri, et al.. (2020). Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center. Supportive Care in Cancer. 29(4). 1825–1835. 27 indexed citations

11.

Maniakas, Anastasios, et al.. (2020). Reconstruction of intraoral oncologic surgical defects with Integra^® bilayer wound matrix. SHILAP Revista de lepidopterología. 9(1). 213–219. 19 indexed citations

12.

Reyes‐Gibby, Cielito C., Jian Wang, Liangliang Zhang, et al.. (2020). Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck. Cancer. 126(23). 5124–5136. 43 indexed citations

13.

Gunn, G. Brandon, Clifton D. Fuller, David I. Rosenthal, et al.. (2019). Xerostomia Impacts Dysgeusia in Oropharyngeal Cancer Patients Treated with Proton Therapy. International Journal of Radiation Oncology*Biology*Physics. 105(1). E414–E415. 1 indexed citations

14.

Chambers, Mark S., et al.. (2019). The Changing Global Market for Australian Coal | Bulletin – September Quarter 2019. Philadelphia Museum of Art Bulletin. 6 indexed citations

15.

Rugo, Hope S., Lasika Seneviratne, J. Thaddeus Beck, et al.. (2017). Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial. The Lancet Oncology. 18(5). 654–662. 145 indexed citations

16.

Bhayani, Mihir K., et al.. (2015). Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia. Thyroid. 25(7). 834–838. 50 indexed citations

17.

Lewis, Carol M., Bonnie S. Glisson, Lei Feng, et al.. (2012). A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research. 18(5). 1435–1446. 131 indexed citations

18.

Lewin, Jan S., et al.. (2012). Customization of the voice prosthesis to prevent leakage from the enlarged tracheoesophageal puncture: Results of a prospective trial. The Laryngoscope. 122(8). 1767–1772. 16 indexed citations

19.

Rosenthal, David I., Tito R. Mendoza, Mark S. Chambers, et al.. (2008). The M. D. Anderson Symptom Inventory–Head and Neck Module, a Patient-Reported Outcome Instrument, Accurately Predicts the Severity of Radiation-Induced Mucositis. International Journal of Radiation Oncology*Biology*Physics. 72(5). 1355–1361. 66 indexed citations

20.

Lemon, James C., Mark S. Chambers, & Jack W. Martin. (1997). Prosthetic Rehabilitation of Patients with Advanced Nonmelanoma Skin Cancer. Clinics in Plastic Surgery. 24(4). 797–815. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact